跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IRINOCAN 40 CONCENTRATE FOR SOLUTION FOR INFUSION 40 MG/ 2 ML - HSA Drug Approval Details
Approvals
/
HSA
/
IRINOCAN 40 CONCENTRATE FOR SOLUTION FOR INFUSION 40 MG/ 2 ML
Approved
THERAPEUTIC
IRINOCAN 40 CONCENTRATE FOR SOLUTION FOR INFUSION 40 MG/ 2 ML
Intas Pharmaceuticals Limited
🇸🇬 Health Sciences Authority
Approval Date
Jul 5, 2019
Approval ID
667f6c321f50c2f7
Company
Intas Pharmaceuticals Limited
Type
Therapeutic
Approval Details
Approval Id
667f6c321f50c2f7
Drug Name
IRINOCAN 40 CONCENTRATE FOR SOLUTION FOR INFUSION 40 MG/ 2 ML
Product Name
IRINOCAN 40 CONCENTRATE FOR SOLUTION FOR INFUSION 40 MG/ 2 ML
Approval Number
SIN15735P
Approval Date
2019-07-05
Registrant
ACCORD HEALTHCARE PRIVATE LIMITED
Licence Holder
ACCORD HEALTHCARE PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INFUSION, SOLUTION CONCENTRATE
Route Of Administration
INTRAVENOUS
Atc Code
L01XX19
Atc Item Name
xl 01 xx 19
Pharma Manufacturer Name
ACCORD HEALTHCARE PRIVATE LIMITED
Company Detail Path
/organization/accord-healthcare-private-limited
Active Ingredients
Irinotecan 34.66 mg eqv Irinotecan Hydrochloride Trihydrate
40 mg/vial
IRINOTECAN 34.66 MG EQV IRINOTECAN HYDROCHLORIDE TRIHYDRATE
40 MG/VIAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 5, 2019
Approval ID
667f6c321f50c2f7
Type
Therapeutic
Back to HSA Approvals
